Related Experiment Videos
Safe techniques in surgery for hysteroscopic myomectomy
Takashi Murakami1, Mitsutoshi Tamura, Yuka Ozawa
1Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Japan. tm@ob-gyn.tohoku.ac.jp
The Journal of Obstetrics and Gynaecology Research
|May 27, 2005
Summary
Hysteroscopic myomectomy is the best treatment for submucous fibroids, but complications can occur. A combined technique using vaporization and prostaglandin F-2alpha offers a safer approach for sessile submucous myomata.
Area of Science:
- Gynecology
- Minimally Invasive Surgery
Background:
- Submucous myomata (fibroids) are commonly treated with hysteroscopic myomectomy.
- This procedure carries risks such as uterine perforation, cervical laceration, hyponatremia, and hemorrhage, particularly with sessile types.
Purpose of the Study:
- To identify safer methods for hysteroscopic myomectomy, especially for challenging sessile submucous myomata.
- To minimize operative time and intramyometrial dissection during hysteroscopic myomectomy.
Main Methods:
- Review of surgical considerations for safe hysteroscopic myomectomy.
- Evaluation of a combined technique involving vaporization and prostaglandin F-2alpha administration.
Main Results:
- Shorter operating times and reduced myometrial cutting are key to safe hysteroscopic myomectomy.
- The combination of vaporization and prostaglandin F-2alpha appears to be a safer method for hysteroresectoscopy.
Conclusions:
- Careful preoperative and intraoperative management is crucial for minimizing complications.
- The proposed combined technique offers a potentially safer approach for removing unpedunculated sessile submucous myomata.